Company / SG&A per Share
Cullinan Therapeutics, Inc. SG&A per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.92
FY2024
5-year range
$0.57 / $1.02
FY2020-FY2024
Trend
-9.7%
vs FY2023
Sector context
#129 of 210
Health Care
What the data says
At $0.92, Cullinan Therapeutics, Inc.'s sg&a per share ranks #82 of 210 in the Health Care sector. Increased from $0.88 to $0.92 over the past 2 years.
Based on SEC 10-K filings.
0.92 in FY2024 with a 3-year CAGR of +17.2%.
Increased from $0.88 to $0.92 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#82 of 210 in Health CareTop 39% of 210This company $0.92 Sector average $40.76
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share decreased 9.7% year-over-year.
- Ranks #129 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.92 | -9.7% |
| FY2023 | $1.02 | +16.5% |
| FY2022 | $0.88 | +52.9% |
| FY2021 | $0.57 | -33.3% |
| FY2020 | $0.86 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026